AstraZeneca PLC (NASDAQ:AZN), a global biopharmaceutical company headquartered in Cambridge, UK, operates in over 130 ...

In an earnings call on July 29th, in which the company reported a 13% increase in half-year profits, he said about Britain ...

AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.

AstraZeneca said Tuesday it's planning to invest $50 billion in expanding its manufacturing and research presence in the U.S. by 2030, as worries about tariffs loom over the industry.

Ahead of the 10-year anniversary of Tagrisso’s FDA approval this fall, AstraZeneca has debuted the first DTC commercial for the lung cancer med.

Pharma AstraZeneca, facing lung cancer challenge from J&J, touts life-extension benefit for Tagrisso combo By Angus Liu Jul 21, 2025 2:59pm AstraZeneca Tagrisso EGFR-mutated lung cancer Johnson ...

WASHINGTON (Reuters) -AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on Monday, the latest big investment by a pharmaceutical ...

AstraZeneca plans to plough billions of pounds into US manufacturing as the drugs giant faces the threat of looming tariffs.

AstraZeneca, a pharmaceutical company, has announced its plans to bring a drug substance manufacturing facility to Virginia.

AstraZeneca plans a $50 billion investment in U.S. facilities by 2030, including a Virginia plant focused on weight loss and metabolic drugs.

AstraZeneca, the U.K.-Swedish pharmaceutical giant, on Tuesday announced a plan to invest some $50 billion in the U.S. in a move hailed by the Trump administration - though much of what it is ...

AstraZeneca CEO Pascal Soriot discusses the company's $50 billion investment in the U.S. economy. Barack Obama responds to Donald Trump's Russia "treason" threats Ozzy Osbourne, heavy metal music ...